News

National Rise in Telehealth Claims Signals Ongoing Growth

National Rise in Telehealth Claims Signals Ongoing Growth

Significant Increase in Telehealth Claims Documented Nationally

The latest data illustrates a noteworthy rise in the percentage of patients utilizing telehealth services. This trend is evident nationally and across all regions, highlighting the growing reliance on remote healthcare solutions.

Tracking the Trends in Telehealth Utilization

In July, the percentage of patients submitting a telehealth claim was reported at 14.4 percent, an increase from the previous month’s 14.3 percent. This 0.9 percent rise indicates a proactive response to telehealth services, which are continuing to adapt and expand amidst changing healthcare dynamics. This data is reflective of the commercially insured population, excluding Medicare and Medicaid, allowing for a clearer picture of private insurance trends.

Regional Insights

Regionally, the statistics reveal varied growth in telehealth usage. The Midwest saw an increase of 0.1 percent, while the South experienced a significant jump of 1.3 percent. The West observed an even higher uptick with a rise of 1.8 percent, and the Northeast led all regions with an impressive 2.6 percent increase. These figures underscore the distinct regional preferences and patterns that may correlate with local healthcare access and technology adoption.

Changing Patterns in Diagnostic Categories

Interestingly, sleep disorders made a comeback in the national top five telehealth diagnostic categories in July, reentering the rankings in fifth place. This category had previously dropped out in June, revealing significant shifts in patient needs and service engagements. Crucially, this change displaced acute respiratory diseases, indicating evolving patient priorities and possibly increased awareness around sleep health.

Expanding Diagnostic Categories

Furthermore, noninflammatory female disorders which appeared as a new entrant in the West during June also gained traction in the Midwest and Northeast by July. This further illustrates the broadening spectrum of health issues being managed through telehealth, highlighting its versatility as a healthcare delivery model.

Urban and Rural Telehealth Utilization Discrepancies

As anticipated, telehealth usage remains more pronounced in urban areas compared to rural locales. Data shows that 14.6 percent of urban patients had a telehealth claim versus only 7.4 percent in rural areas. The divide is most pronounced in the West, where urban usage stands at 19.3 percent compared to 8.0 percent in rural regions, emphasizing the challenges rural patients may face in accessing telehealth services effectively.

Age Demographics of Telehealth Users

When examining age demographics, individuals aged 31-40 represented the largest group engaging with telehealth services, with a notable 23.1 percent having claims. Closely following were patients aged 19-30 at 22.2 percent. This highlights a trend where younger adults are more actively leveraging telehealth for their healthcare needs, whereas individuals over 65 comprised a smaller fraction of the claims, suggesting potential barriers to access or willingness.

Top Procedure Categories in Telehealth

The trends in telehealth claims also revealed shifts in the types of procedures commonly associated with remote care. Psychotherapy and established patient office services were the leading procedures in July. Notably, established patient office services held the top spot nationally at 48.0 percent, while psychotherapy maintained high engagement as well. The continuous pairing of these services in telehealth contexts reflects an ongoing commitment to providing mental health support during times when traditional access might be limited.

The Importance of Telehealth Tracking

The Monthly Telehealth Regional Tracker, initiated in May 2020, serves as a crucial resource for monitoring how telehealth trends evolve from month to month. This tool not only reflects the changing landscape of healthcare provision but also helps stakeholders understand the diverse needs of patients across regions. Through this tracker, users can visualize varying telehealth utilizations from diagnostic categories to urban-rural explorations, equipping them with vital insights.

Frequently Asked Questions

What factors contributed to the rise in telehealth claims?

The rise can be attributed to increasing patient acceptance of telehealth, greater flexibility in scheduling appointments, and expanded availability of services across regions.

How do urban and rural telehealth utilization rates compare?

Urban areas demonstrate significantly higher utilization rates, indicating challenges faced by rural populations in accessing telehealth services.

What are the top diagnostic categories for telehealth?

In July, mental health conditions and sleep disorders were among the top ranked diagnostic categories, demonstrating the critical issues being addressed through telehealth.

How has the age demographic for telehealth claims shifted?

The 31-40 age group now represents the largest percentage of telehealth users, followed closely by young adults aged 19-30, indicating a preference in younger populations for remote healthcare.

What is the purpose of the Monthly Telehealth Regional Tracker?

This tracker monitors and displays evolving telehealth trends, providing insights on utilization patterns and diagnostic categories to help healthcare stakeholders navigate changes in patient behaviors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cardinal Health Surges with Increased EPS Outlook

Updated Category News Views 111

Cardinal Health's Towering Numbers and Raised Outlook Holy moly, Cardinal Health is strutting out of the gate like they mean business. Their first quarter for fiscal year 2027 showed revenue hitting a hefty $67.5 billion—up 5% from last year. If you're holding NYSE:CAH, you might be grinning ear to ear right now. Cardinal didn’t just squeeze out more revenue; they saw...

Continue Reading
Verismo's SynKIR™-310 Shows Promise in Phase 1 Trials

Updated Category News Views 74

KIR-CAR: A Fresh Take on Cancer Treatment So, Verismo Therapeutics is at it again with their KIR-CAR platform. They're set to present interim data at this year's ASH Annual Meeting. To all those following B-cell non-Hodgkin Lymphoma (B-NHL) treatments, pay attention. SynKIR™-310, a CD19-targeted therapy, is showing some real promise. The science behind this is like...

Continue Reading
Mondego Bio Charges Ahead with Cancer Therapy Trials

Updated Category News Views 78

Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...

Continue Reading
Chris Auffenberg Delivers Ford Blue Advantage Gains

Updated Category News Views 18

Can't Ignore Ford's New Strategy in Pre-Owned Cars The auto industry may feel like a runaway train sometimes, and keeping up with the latest turns can be a headache. But here's something catching my eye: Chris Auffenberg Ford's new move with the Ford Blue Advantage certified pre-owned vehicles. It's not just any run-of-the-mill used car deal—this one's got some beef...

Continue Reading
Reviving Carbide Tools: Resharpening for Cost Control

Updated Category News Views 52

Trading Rust: Resharpening Carbide Cutting Tools Alright, picture this: you've got a toolbox full of worn carbide tools, each looking like they've seen better days. You might toss 'em out and grab some new ones, right? But hold on! Carl Ciesla, a cutting tool vet from Sanborn, NY, is talking all about how resharpening could be your ticket to saving a heap of cash and...

Continue Reading
Norwegian Cruise Line's Black Friday Big Splash

Updated Category News Views 65

Jump Aboard NCL's Black Friday Bargain Ship Grab your life jackets, folks! Norwegian Cruise Line (NCL) is sailing with an irresistible Black Friday offer: 50% off all cruises, complete with their much-lauded Free at Sea package. Yeah, if you've been fence-sitting about taking the plunge into the cruise lifestyle, now might just be the time to buckle up your life vests. A...

Continue Reading
Bioactive Research: Converting Science into Guidance

Updated Category News Views 0

Unlocking the Science of Dietary Bioactives Amidst a world swimming in kale smoothies and exotic teas, ILSI U.S. & Canada gathered the sharpest minds to discuss dietary bioactives, an area once shrugged off but now coming into its own. On October 28, 2026, over 250 folks from government, academia, and industry tuned in, looking to understand how these compounds, found in...

Continue Reading
Aker Solutions Lands Big Role in Qatar Oil Upgrade

Updated Category News Views 88

Qatari Venture Beckons Aker Solutions Well, it's not every day you hear about a decades-old oil field getting a facelift, and yet here we are. Aker Solutions has received a nod of approval with a letter of award from PTSC Mechanical and Construction Limited Company (PTSC M&C). This gig is all about the Maydan Mahzam oil field way off the Qatari coast—a legacy site...

Continue Reading
Utility Returns: Short-Term Savings, Long-Term Costs

Updated Category News Views 64

Crunching the Numbers on Utility Returns There's a buzz in the utility sector, and it's not just the hum of power lines—it’s all about return on equity (ROE). Concentric Energy Advisors just dropped some insights that could have us rethinking how these returns play into customer bills and utilities' financing capabilities. What's the Deal with ROE? Think of ROE like a...

Continue Reading
Qfin Faces Stock Lawsuit: Know Your Investor Rights

Updated Category News Views 82

Qfin in the Legal Hot Seat When you hear about a company's legal wranglings, especially one like Qfin Holdings, Inc., you've got to sit up and take notice. We're not talking about a quick scuffle here; this is a full-blown class action lawsuit with its talons sunk deep into allegations of securities law violations. They're squared off against DJS Law Group, an outfit that...

Continue Reading

Top 5 Most Recently Viewed Articles

M-DAQ Expands Footprint: Eyes Vietnam's Booming Economy

Updated Category News Views 51

Strategic Moves in the ASEAN Financial Arena Now, this one's got some bite to it. M-DAQ Global's foray into Vietnam isn't just another step on the fintech ladder - it's a bold expansion play into one of ASEAN's fastest up-and-comers. Forget the usual corporate fluff; what we're seeing here is a calculated strike to grab a piece of a pie that's only getting bigger. Why...

Continue Reading
IDEAYA Biosciences, Inc. Reports Strong Progress in 2024

Updated Category News Views 194

IDEAYA Biosciences, Inc. Achieves Significant Milestones in Financial Reporting IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a pioneering precision medicine oncology company, recently shared its financial results for the fourth quarter and the full year of 2024. The company is dedicated to the discovery and development of targeted therapeutics, making noteworthy strides...

Continue Reading
5N Plus Inc. Enhances Supply Partnership with First Solar

Updated Category News Views 256

Introduction to the New Supply Agreement 5N Plus Inc. (TSX: VNP), a global leader in specialty semiconductors and performance materials, recently announced a major expansion of its supply agreement with First Solar, Inc. (NASDAQ: FSLR). This partnership is vital in supplying increased volumes of critical materials essential for the production of photovoltaic solar...

Continue Reading
Energy Services of America Shines at Upcoming Investor Conference

Updated Category News Views 162

Highlighting Energy Services of America's Upcoming Investor Conference Energy Services of America (NASDAQ: ESOA) is preparing to make a significant impact at an upcoming investor conference. The event will feature presentations by the company's top executives, providing insights into the organization’s future strategies and objectives. Key Presenters at the Conference...

Continue Reading
Ophthalmic Drugs Market Expected to Hit $67.83 Billion by 2033

Updated Category News Views 51

Overview of the Ophthalmic Drugs Market The ophthalmic drugs market is experiencing impressive growth, largely due to the increasing prevalence of eye diseases and innovative advancements in drug development. In 2023, the market was valued at USD 37.17 billion and is expected to grow at a remarkable CAGR of 6.2% from 2024 to 2033, surpassing USD 67.83 billion. Recent...

Continue Reading